Does TIPIRACIL\TRIFLURIDINE Cause Malignant neoplasm progression? 182 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 182 reports of Malignant neoplasm progression have been filed in association with TIPIRACIL\TRIFLURIDINE. This represents 1.8% of all adverse event reports for TIPIRACIL\TRIFLURIDINE.
182
Reports of Malignant neoplasm progression with TIPIRACIL\TRIFLURIDINE
1.8%
of all TIPIRACIL\TRIFLURIDINE reports
64
Deaths
59
Hospitalizations
How Dangerous Is Malignant neoplasm progression From TIPIRACIL\TRIFLURIDINE?
Of the 182 reports, 64 (35.2%) resulted in death, 59 (32.4%) required hospitalization, and 4 (2.2%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TIPIRACIL\TRIFLURIDINE. However, 182 reports have been filed with the FAERS database.
What Other Side Effects Does TIPIRACIL\TRIFLURIDINE Cause?
Death (3,017)
Disease progression (1,774)
Fatigue (1,298)
Nausea (1,135)
Diarrhoea (965)
Decreased appetite (659)
Vomiting (628)
White blood cell count decreased (483)
Asthenia (472)
Anaemia (388)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which TIPIRACIL\TRIFLURIDINE Alternatives Have Lower Malignant neoplasm progression Risk?
TIPIRACIL\TRIFLURIDINE vs TIPRANAVIR
TIPIRACIL\TRIFLURIDINE vs TIRAGOLUMAB
TIPIRACIL\TRIFLURIDINE vs TIRBANIBULIN
TIPIRACIL\TRIFLURIDINE vs TIROFIBAN
TIPIRACIL\TRIFLURIDINE vs TIRZEPATIDE